← back to search

Benjamin Purow

University of Virginia Cancer Center · US
Area of research
Cancer Research · Genetics
Research interest
Research interests include Glioma Diagnosis and Treatment, MicroRNA in disease regulation, Circular RNAs in diseases, and Cancer Research and Treatments.
h-index
40
citations
10,105
works
210
NIH funding
primary concept
Medicine
email

Recent publications

A dangerous chip off the old block promoting brain metastasis in inflammatory breast cancer.
2026cited by 0position: contributordoi
Belzutifan-induced tumor regression in sporadic hemangioblastoma: a case report and literature review.
2026cited by 0position: contributordoi
Synergistic activity of simvastatin and irinotecan chemotherapy against glioblastoma converges on TGF-β signaling.
2025cited by 1position: contributordoi
Potential synergism of abemaciclib with chloroquine and disulfiram/copper in atypical meningioma: A case report and review of the literature.
2025cited by 0position: contributordoi
Understanding current experimental models of glioblastoma-brain microenvironment interactions.
2024cited by 13position: contributordoi
Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling
Cancer Cell 2023cited by 79position: middledoi
Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner.
2021cited by 18position: contributordoi
The nuclear DICER–circular RNA complex drives the deregulation of the glioblastoma cell microRNAome
Science Advances 2020cited by 49position: middledoi
Statins affect human glioblastoma and other cancers through TGF-β inhibition
Oncotarget 2019cited by 38position: lastdoi
Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma
Cancer Research 2018cited by 64position: lastdoi
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
The Lancet Oncology 2017cited by 1,105position: middledoi
Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms
Clinical Cancer Research 2017cited by 108position: lastdoi
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha
Neuro-Oncology 2017cited by 64position: lastdoi
CDK4/6 inhibition is more active against the glioblastoma proneural subtype
Oncotarget 2017cited by 50position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jeongwu Lee · Cleveland Clinic Lerner College of Medicine6 papers (2017–2023)Jakub Godlewski · The Ohio State University6 papers (2017–2020) · 6 papers (2021–2026)Agnieszka Bronisz · The Ohio State University6 papers (2017–2020)Ichiro Nakano · University of Alabama at Birmingham6 papers (2017–2020)Inan Olmez · University of Virginia5 papers (2017–2019)Breanna Brenneman · University of Virginia4 papers (2017–2019)Aizhen Xiao · University of Virginia4 papers (2017–2019)Laryssa Manigat · University of Virginia3 papers (2017–2018)Desiree H. Floyd · University of Virginia3 papers (2017–2019)Roger Abounader · University of Virginia3 papers (2017–2018)Ming Li · Henan Academy of Agricultural Sciences2 papers (2017–2017)Mouadh Benamar · University of Virginia2 papers (2017–2018)Tarek Abbas · University of Virginia2 papers (2017–2018)Erik P. Sulman · Duke University2 papers (2017–2017)Brian D. McKenna · University of Virginia1 papers (2017–2017)Peyton Randolph · University of Virginia1 papers (2017–2017)Daniel Gioeli · University of Virginia1 papers (2017–2017) · 1 papers (2020–2020)Sung Soo Kim · Seoul National University1 papers (2023–2023)